Apexigen, Inc. Total Liabilities and Equity
Apexigen, Inc. had Total Liabilities and Equity of $13.08 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2023-08-10
- 2023-06-30: Liabilities and Equity $13.08M.
- 2023-03-31: Liabilities and Equity $17.58M.
- 2022-12-31: Liabilities and Equity $22.86M.
- 2022-09-30: Liabilities and Equity $27.57M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2023-06-30 | $13.08M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $17.58M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $22.86M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $27.57M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $51.82M 10-Q · filed 2022-08-18 | |
| 2022-03-31 | $58.28M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $39.10M 10-K · filed 2023-02-22 | $58.32M 10-K · filed 2022-04-07 |
| 2021-09-30 | $58.42M 10-Q · filed 2021-12-09 | |
| 2021-06-30 | $58.55M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $58.68M 10-Q · filed 2021-06-07 | |
| 2020-12-31 | $97.25K 10-K · filed 2022-04-07 |